serine has been researched along with Movement Disorders in 11 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nausea and cardiac arrhythmias are lessened, as are the incidence and severity of hypotension." | 1.25 | Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease. ( Barbeau, A; Botez, MI; Joubert, M; Mars, H, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, WR | 1 |
| Jen, HI | 1 |
| Seymour, ML | 1 |
| Yeh, SY | 1 |
| Pereira, FA | 1 |
| Groves, AK | 1 |
| Klisch, TJ | 1 |
| Zoghbi, HY | 1 |
| Mirelman, A | 1 |
| Saunders-Pullman, R | 1 |
| Alcalay, RN | 1 |
| Shustak, S | 1 |
| Thaler, A | 1 |
| Gurevich, T | 1 |
| Raymond, D | 1 |
| Mejia-Santana, H | 1 |
| Orbe Reilly, M | 1 |
| Ozelius, L | 1 |
| Clark, L | 1 |
| Gana-Weisz, M | 1 |
| Bar-Shira, A | 1 |
| Orr-Utreger, A | 1 |
| Bressman, SB | 1 |
| Marder, K | 1 |
| Giladi, N | 1 |
| Febbraro, F | 1 |
| Sahin, G | 1 |
| Farran, A | 1 |
| Soares, S | 1 |
| Jensen, PH | 1 |
| Kirik, D | 1 |
| Romero-Ramos, M | 1 |
| Mougenot, AL | 1 |
| Nicot, S | 1 |
| Bencsik, A | 1 |
| Morignat, E | 1 |
| Verchère, J | 1 |
| Lakhdar, L | 1 |
| Legastelois, S | 1 |
| Baron, T | 1 |
| Kay, DM | 1 |
| Zabetian, CP | 1 |
| Factor, SA | 1 |
| Nutt, JG | 1 |
| Samii, A | 1 |
| Griffith, A | 1 |
| Bird, TD | 1 |
| Kramer, P | 1 |
| Higgins, DS | 1 |
| Payami, H | 1 |
| Shang, HF | 1 |
| Jiang, XF | 1 |
| Burgunder, JM | 1 |
| Chen, Q | 1 |
| Zhou, D | 1 |
| Kondo, T | 1 |
| Korten, JJ | 1 |
| Keyser, A | 1 |
| Joosten, EM | 1 |
| Gabreëls, FJ | 1 |
| Yamamoto, M | 1 |
| Ujike, H | 1 |
| Ogawa, N | 1 |
| Barbeau, A | 1 |
| Mars, H | 1 |
| Botez, MI | 1 |
| Joubert, M | 1 |
| Boggan, WO | 1 |
| Seiden, LS | 1 |
1 trial available for serine and Movement Disorders
| Article | Year |
|---|---|
Madopar versus sinemet. A clinical study on their effectiveness.
Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydr | 1975 |
10 other studies available for serine and Movement Disorders
| Article | Year |
|---|---|
An Atoh1-S193A Phospho-Mutant Allele Causes Hearing Deficits and Motor Impairment.
Topics: Aging; Alleles; Animals; Basic Helix-Loop-Helix Transcription Factors; Female; Gene Knock-In Techniq | 2017 |
Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
Topics: Adult; Aged; Aged, 80 and over; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protei | 2018 |
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Behavior, Animal; Blotting, Western; Corpus Striatum; Densitometry; Depend | 2013 |
Prion-like acceleration of a synucleinopathy in a transgenic mouse model.
Topics: Age Factors; Animals; Disease Models, Animal; Humans; Intermediate Filament Proteins; Mice; Mice, In | 2012 |
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Fe | 2006 |
Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus.
Topics: Ceruloplasmin; Cognition Disorders; Diabetes Complications; DNA Mutational Analysis; Exons; Female; | 2006 |
[D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
Topics: Aged; Droxidopa; Female; Gait; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parki | 1984 |
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydro | 1985 |
Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Benzyl Compounds; D | 1972 |
Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
Topics: Animals; Behavior, Animal; Benzyl Compounds; Brain Chemistry; Dihydroxyphenylalanine; Dopa Decarboxy | 1971 |